ChemPartner PharmaTech Co.,Ltd. (SHE:300149)

China · Delayed Price · Currency is CNY

8.80

+0.21 (2.44%)

Nov 5, 2026, 4:00 PM EST

ChemPartner PharmaTech Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	1,265	1,135	970.2	1,138	1,327	1,691
Revenue Growth	18.40%	16.96%	-14.77%	-14.19%	-21.54%	14.11%
Gross Profit	347.05	326.7	202.6	279	327.04	532.22
Operating Income	38.39	9.62	-97.26	-65.57	-95.56	65.31
Net Income	-7	13.41	-226.47	-916.75	378.59	-402.25
Earnings Per Share	-0.02	0.03	-0.45	-1.84	0.76	-0.81
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Offset of Business Segment	-16.73
Headquarters and Funds	5.39
Big Health and Medical Business	8.98
Pharmaceutical R & D Services and Production Outsourcing	1,137
Total	1,135

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	440.17	457.39	369.37	349.47	761.66	179.44
Total Debt	488.04	472.04	513.31	635.34	966.2	1,747
Net Cash (Debt)	-47.87	-14.65	-143.93	-285.88	-204.53	-1,568
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.11	-0.03	-0.29	-0.57	-0.41	-3.16

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	171.42	190.5	168.21	150.99	262.46	378.22
Capital Expenditures	-87.22	-62.47	-69.25	-201.29	-336.2	-286
Free Cash Flow	84.2	128.03	98.96	-50.3	-73.74	92.22
Free Cash Flow Growth	-31.82%	29.37%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	27.43%	28.79%	20.88%	24.51%	24.65%	31.48%
Operating Margin	3.03%	0.85%	-10.03%	-5.76%	-7.20%	3.86%
Pretax Margin	-0.86%	1.41%	-23.88%	-82.55%	56.14%	-21.35%
Profit Margin	-0.55%	1.18%	-23.34%	-80.53%	28.54%	-23.79%
FCF Margin	6.65%	11.28%	10.20%	-4.42%	-5.56%	5.46%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	-	354.94	-	-	13.69	-
Forward PE	-	21.25	21.25	21.25	21.25	21.25
P/FCF Ratio	52.78	37.18	32.19	-	-	74.63
PS Ratio	3.51	4.20	3.28	3.35	3.91	4.07